Hjem › Osteosarkom › Texas › Dallas
Osteosarkom kliniske forsøg i Dallas, TX
5 studier for Osteosarkom søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RekruttererFase 2
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RekruttererFase 1/2
- Children's Medical Center, Dallas
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
RekruttererFase 1/2
- Children's Medical Center, Dallas
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RekruttererFase 3
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RekruttererObservationsstudie
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Osteosarkom forsøg i andre byer
- Memphis, TN10 studier
- Atlanta, GA10 studier
- St. Louis, MO10 studier
- Boston, MA9 studier
- Mountain View, CA8 studier
- Los Angeles, CA7 studier
- Chicago, IL7 studier
- Birmingham, AL7 studier
- Houston, TX7 studier
- Tampa, FL6 studier
- Philadelphia, PA6 studier
- New York City, NY6 studier
Andre studier i Dallas
- Brystkræft55 studier
- Ikke-småcellet lungecancer52 studier
- Metastatisk cancer42 studier
- Hjertesvigt42 studier
- Kræft (alle typer)37 studier
- Prostatakræft36 studier
- Colorektal kræft33 studier
- Overvægt30 studier
- Ægstockræft28 studier
- Blærecancer27 studier
- Lungecancer27 studier
- Livmoderslimhindekræft24 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.